Literature DB >> 7797587

The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin.

P A Pemberton1, D T Wong, H L Gibson, M C Kiefer, P A Fitzpatrick, R Sager, P J Barr.   

Abstract

The role of tumor suppressor proteins in the development of malignancy has made the understanding of their molecular mechanisms of action of great importance. Maspin is a tumor suppressor produced by a number of cell types of epithelial origin. Exogenous recombinant maspin has been shown to block the growth, motility, and invasiveness of breast tumor cell lines in vitro and in vivo. Although belonging to the the serine proteinase inhibitor (serpin) superfamily of proteins, the molecular mechanism of maspin is currently unknown. Here we show that the reactive site loop of maspin exists in an exposed conformation that does not require activation by cofactors. The reactive site loop of maspin, however, does not act as an inhibitor of proteinases such as chymotrypsin, elastase, plasmin, thrombin, and trypsin but rather as a substrate. Maspin is also unable to inhibit tissue and urokinase type plasminogen activators. Stability studies show that maspin cannot undergo the stressed-relaxed transition typical of proteinase-inhibitory serpins, and the protein is capable of spontaneous polymerization induced by changes in pH. It is likely, therefore, that maspin is structurally more closely related to ovalbumin and angiotensinogen, and its tumor suppressor activity is independent of a latent or intrinsic trypsin-like serine proteinase-inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797587     DOI: 10.1074/jbc.270.26.15832

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.

Authors:  M Zhang; S Sheng; N Maass; R Sager
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer.

Authors:  Efthimia Tsoli; Petros K Tsantoulis; Alexandros Papalambros; Branko Perunovic; David England; David A Rawlands; Gary M Reynolds; Dimitrios Vlachodimitropoulos; Susan L Morgan; Chara A Spiliopoulou; Thanos Athanasiou; Vassilis G Gorgoulis
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

3.  Polymerization of human angiotensinogen: insights into its structural mechanism and functional significance.

Authors:  Peter Stanley; Louise C Serpell; Penelope E Stein
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

4.  HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells.

Authors:  Xiaohua Li; Alexander Kaplun; Fulvio Lonardo; Elisabeth Heath; Fazlul H Sarkar; Jonathan Irish; Wael Sakr; Shijie Sheng
Journal:  Mol Cancer Res       Date:  2011-05-26       Impact factor: 5.852

5.  Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.

Authors:  M Margarida Bernardo; Yonghong Meng; Jaron Lockett; Gregory Dyson; Alan Dombkowski; Alexander Kaplun; Xiaohua Li; Shuping Yin; Sijana Dzinic; Mary Olive; Ivory Dean; David Krass; Kamiar Moin; R Daniel Bonfil; Michael Cher; Wael Sakr; Shijie Sheng
Journal:  Genes Cancer       Date:  2011-11

6.  Identification of Serpinb6b as a species-specific mouse granzyme A inhibitor suggests functional divergence between human and mouse granzyme A.

Authors:  Dion Kaiserman; Sarah E Stewart; Kim Plasman; Kris Gevaert; Petra Van Damme; Phillip I Bird
Journal:  J Biol Chem       Date:  2014-02-06       Impact factor: 5.157

7.  Maspin suppresses survival of lung cancer cells through modulation of Akt pathway.

Authors:  Eunsook Nam; Chaehwa Park
Journal:  Cancer Res Treat       Date:  2010-03-31       Impact factor: 4.679

8.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.

Authors:  S Sheng; J Carey; E A Seftor; L Dias; M J Hendrix; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

9.  Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.

Authors:  Mark A Horswill; Malathi Narayan; Debra J Warejcka; Lisa A Cirillo; Sally S Twining
Journal:  Exp Eye Res       Date:  2008-01-12       Impact factor: 3.467

10.  Binding of extracellular maspin to beta1 integrins inhibits vascular smooth muscle cell migration.

Authors:  Rosemary Bass; Laura Wagstaff; Lorna Ravenhill; Vincent Ellis
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.